Options Trading News

September 30, 2013  Mon 7:32 AM CT


Liver Complications Won't Go Away

Achillion Pharmaceuticals said the U.S. Food & Drug Administration kept its experimental hepatitis C drug sovaprevir on hold. The company had tried to address regulators' concerns earlier in the year, but liver complications remain a problem. ACHN plunges more than 50 percent before the opening bell on my tradeMONSTER platform.

Morgan Stanley Downgrades Panera

Panera Bread was downgraded to "equal weight" from "overweight" by Morgan Stanley, which says Chipotle Mexican Grill might do a better job driving sales. PNRA falls 2 percent in the premarket and CMG inches higher.

Share this article with your friends



The fastest money in the market
View full report »

Premium Services

Archived Webinar

Education & Strategy

The covered call and unhedged risk

I have written a few things on the Covered Call Strategy over the last two weeks. Please understand that those two previous articles plus this one do not constitute a proper, fully in-depth lesson on the Covered Call Strategy like we have in our classes at Option Monster Education. I have picked out a few topics that I believe were worth noting and today I am going to add the final one.

View more education articles »